Cargando…

Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia

BACKGROUND: The majority of individuals with acute myeloid leukemia (AML) respond to initial chemotherapy and achieve a complete remission, yet only a minority experience long-term survival because a large proportion of patients eventually relapse with therapy-resistant disease. Relapse therefore re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hackl, Hubert, Astanina, Ksenia, Wieser, Rotraud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322789/ https://www.ncbi.nlm.nih.gov/pubmed/28219393 http://dx.doi.org/10.1186/s13045-017-0416-0

Ejemplares similares

A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes
por: Hackl, Hubert, et al.
Publicado: (2015)

Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A
por: Grandits, Alexander M., et al.
Publicado: (2021)

Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness
por: Grandits, Alexander Michael, et al.
Publicado: (2021)

Overexpression of primary microRNA 221/222 in acute myeloid leukemia
por: Rommer, Anna, et al.
Publicado: (2013)

CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia
por: Gluexam, Tobias, et al.
Publicado: (2019)

Tetracycline Regulator Expression Alters the Transcriptional Program of Mammalian Cells
por: Hackl, Hubert, et al.
Publicado: (2010)

Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes
por: Konrad, Torsten A., et al.
Publicado: (2009)

All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia
por: Nguyen, Chi Huu, et al.
Publicado: (2019)

All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells
por: Nguyen, Chi H., et al.
Publicado: (2020)

The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid
por: Steinmetz, Birgit, et al.
Publicado: (2014)

Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia
por: Chyla, Brenda, et al.
Publicado: (2018)

Treatment of Relapsed Acute Myeloid Leukemia
por: Thol, Felicitas, et al.
Publicado: (2020)

Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia
por: Petti, Allegra A., et al.
Publicado: (2022)

Acute Myeloid Leukemia—Genetic Alterations and Their Clinical Prognosis
por: Lagunas-Rangel, Francisco Alejandro, et al.
Publicado: (2017)

Molecular Genetic Markers in Acute Myeloid Leukemia
por: Yohe, Sophia
Publicado: (2015)

Treatment for Relapsed/Refractory Acute Myeloid Leukemia
por: Thol, Felicitas, et al.
Publicado: (2021)

Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
por: Yilmaz, Musa, et al.
Publicado: (2019)

Recent advances of targeted therapy in relapsed/refractory acute myeloid leukemia
por: Ma, Jiale, et al.
Publicado: (2021)

Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia
por: Dadrass, Farinoosh, et al.
Publicado: (2022)

Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells
por: Nguyen, Chi Huu, et al.
Publicado: (2020)

Isolated Intracranial Myeloid Sarcoma Occurring as Relapse in Acute Myeloid Leukemia
por: Narayanan, Geetha, et al.
Publicado: (2017)

Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia
por: Pessoa, Flávia Melo Cunha de Pinho, et al.
Publicado: (2023)

Relapsing acute myeloid leukemia presenting as hypopyon uveitis
por: Hegde, Sapna P, et al.
Publicado: (2011)

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
por: Goswami, Meghali, et al.
Publicado: (2022)

Resistance to targeted therapies in acute myeloid leukemia
por: Mecklenbrauck, Rabea, et al.
Publicado: (2022)

Colonic Myeloid Sarcoma as a Rare Presentation of Relapsed Acute Myeloid Leukemia
por: Phatharacharukul, Parkpoom, et al.
Publicado: (2020)

Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics
por: Sahoo, Ranjit Kumar, et al.
Publicado: (2013)

Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia
por: Mumme, Hope, et al.
Publicado: (2023)

Molecular landscape and targeted therapy of acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2018)

Cutting Edge Molecular Therapy for Acute Myeloid Leukemia
por: Miyamoto, Kenichi, et al.
Publicado: (2020)

Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia
por: Obszański, Piotr, et al.
Publicado: (2022)

Treatment of relapsed undifferentiated acute myeloid leukemia (AML-M0) with Ayurvedic therapy
por: Prakash, Balendu
Publicado: (2011)

Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
por: Ramos, Nestor R., et al.
Publicado: (2015)

Clonal evolution of acute myeloid leukemia from diagnosis to relapse
por: Vosberg, Sebastian, et al.
Publicado: (2019)

Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia
por: Rapaport, Franck, et al.
Publicado: (2021)

Brachytherapy for uterine cervix-limited acute myeloid leukemia relapse
por: Beziat, Guillaume, et al.
Publicado: (2022)

Venetoclax with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia
por: Bouligny, Ian M., et al.
Publicado: (2023)

Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia
por: Nuno, Kevin A., et al.
Publicado: (2023)

CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
por: Farge, Thomas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eiq7nbuqas38o9mluu03t1dg4v